Medical News

RSS

'Budget reconciliation' still part of health bill strategy discussions

Talk about using budget reconciliation to pass healthcare reform in the Senate has faded from public view, but Democratic leaders continue to hang the threat over centrists in private. Senate Majority Leader Harry Reid (D-Nev.) discussed reconciliation with wavering centrists before an important procedural vote to begin debate on healthcare reform.

1 Dec 2009

Palatin Technologies issued U.S. patent covering its lead heart failure drug candidate

Palatin Technologies, Inc. today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,622,440, titled "Cyclic Natriuretic Peptide Constructs." The claims in the issued patent cover a family of cyclic compounds that bind to natriuretic peptide receptor A (NPRA), including PL-3994, Palatin's lead heart failure drug candidate.

1 Dec 2009

NIH Library subscribes to Computable Genomix' GeneIndexer

Memphis-based Computable Genomix today announced that the National Institutes of Health Library has purchased a subscription to its premier product, GeneIndexer, an online genomics research tool.

1 Dec 2009

Positive results from Ardea Biosciences' ongoing drug-drug interaction study of RDEA594 and febuxostat

Ardea Biosciences, Inc. announced positive results from the first dosing group of an ongoing drug-drug interaction and pharmacodynamic study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and febuxostat (Uloric®, Takeda Pharmaceutical Company Limited; Adenuric®, Ipsen). This

1 Dec 2009

MedImmune to develop and commercialize Trellis Bioscience's anti-RSV antibodies

Trellis Bioscience, Inc. announced today the granting of a worldwide exclusive license to MedImmune, LLC, the global biologics unit of AstraZeneca, to develop and commercialize Trellis’ antibodies directed against the respiratory syncytial virus (RSV).

1 Dec 2009

Bioequivalence and comparable toxicity of ADVENTRX Pharmaceuticals' ANX-514 and Taxotere affirmed

ADVENTRX Pharmaceuticals, Inc. today announced that a new, recently completed preclinical study has affirmed the bioequivalence and comparable toxicity of ANX-514 and Taxotere® (docetaxel). Shin Poong Pharmaceuticals, ADVENTRX's partner for ANX-514 in South Korea, independently conducted the study and data analysis.

1 Dec 2009

Chinese SFDA approves Tianyin Pharmaceutical's Pediatric Fever and Cough Oral Liquid

Tianyin Pharmaceutical Co., Inc.,, a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that it has received approvals from the Chinese State Food and Drug Administration (SFDA) to produce Pediatric Fever and Cough Oral Liquid in dosage form of 10 ml/tube (SFDA approval number Z20093060) and Antibacterial and Anti-inflammatory Capsules in dosage form of 0.27 gram/capsule (SFDA approval number Z20090855).

1 Dec 2009

Sentinelle Medical showcases its new line of breast MRI coils at the RSNA meeting

Sentinelle Medical Inc., a leading manufacturer of breast MRI coils and 4D advanced visualization software, extends its line of award winning breast coils at this year's Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 30 - Dec. 5, 2009 (Booth 5800, Hall A).

1 Dec 2009

Positive data from Provectus Pharmaceuticals' psoriasis and atopic dermatitis trials

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced preliminary data for the company’s PH-10 Phase 2 clinical trial for Psoriasis as well as for its Phase 2 clinical trial for Atopic Dermatitis.

1 Dec 2009

Drug risk disclosures not read due to information overload, condensed version needed

When it comes to risk disclosures made by drug companies in print and television ads, many consumers are not paying attention, according to a recent study by ORC Guideline (an infoGROUP company). The latest study in the company’s Under the Skin series found that 41% of US consumers pay little or no attention to risk information presented by pharmaceutical companies in their TV commercials, and only half (50%) pay attention to such disclosures in print ads. This lack of attention is most prevalent among those 55 years of age or older.

1 Dec 2009

Royal Philips Electronics highlights its interventional radiology/oncology solutions at the RSNA meeting

On display at this year's Radiological Society of North America (RSNA) annual meeting, Royal Philips Electronics is highlighting its portfolio in the field of interventional radiology/oncology. The company is developing innovative image-guidance technologies for increasing the range and quality of minimally-invasive interventions and therapies.

From Philips Healthcare 1 Dec 2009

Driscoll Children's Hospital implements the CAREt bedside medication administration system

PatientSafe Solutions, Inc., formerly IntelliDOT(TM) Corporation, an industry expert in patient safety systems for hospitals, announced today an agreement to deploy its innovative bedside medication administration system, CAREt System, at Driscoll Children's Hospital, Corpus Christi, TX.

1 Dec 2009

FORMA Therapeutics closes Series B financing to a total of $25.5 million

FORMA Therapeutics today announced that it has closed on a Series B financing that raised a total of $25.5 million. The round was led by new investor Lilly Ventures, with participation from existing investors Novartis Option Fund and Bio*One Capital of Singapore.

1 Dec 2009

Human-animal bond offers significant benefits

A pet owner knows the enormous joy and comfort that an animal can provide, especially in troubled times. Most pets are considered important members of the family and irreplaceable companions.

1 Dec 2009

Optoacoustics' FOMRI-III optical microphone now available for use in fMRI environments

Optoacoustics has announced availability of the FOMRI-III(TM) dual channel microphone, the most advanced optical microphone available for use in functional magnetic resonance imaging (fMRI) environments.

1 Dec 2009

Toshiba launches new education plan for healthcare staff

In today’s fast-paced health care environment, it is critical that hospitals keep their staff updated on using the latest imaging technology available. Currently, most facilities receive the majority of their diagnostic imaging equipment training when a new system is delivered. Toshiba America Medical Systems, Inc. recognizes the importance of maintaining that training edge and now is providing customers with an option – Performance Plus.

1 Dec 2009

UC3M researchers developing a prototype for extracting drug interactions

A pharmacological interaction occurs when the effects of a one drug are modified by the presence of another. The consequences can be harmful if the interaction causes an increase in the toxicity of the drug or if it diminishes its effect, possibly even causing the patient's death, in the worst case scenario. At present, there are databases for checking possible interactions between drugs administered to patients, but the main problem is that many of the databases are not updated for three years.

1 Dec 2009

New figures show steady decline in European cancer deaths, but variations exist between gender and countries

New figures show there was a steady decline in cancer deaths in the European Union between 1990-1994 and 2000-2004.

1 Dec 2009

Pfizer, Protalix team up to develop and market plant-based enzyme for Gaucher’s disease treatment

Pfizer and Protalix (NYSE-Amex: PLX) today announced that they have entered into an agreement to develop and commercialize taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD) in development for the potential treatment of Gaucher’s disease.

1 Dec 2009

50 U.S. Hospitals approve Osteotech's Plexur M bone-polymer biocomposite

Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that Plexur M® (moldable), a bone-polymer biocomposite built upon the Company's proprietary Plexur® technology platform, has been approved for use by 50 U.S. hospitals to date. The Company expects to receive additional approvals as Plexur M continues to gain mindshare among surgeons.

1 Dec 2009

Medical News

'Budget reconciliation' still part of health bill strategy discussions

Palatin Technologies issued U.S. patent covering its lead heart failure drug candidate

NIH Library subscribes to Computable Genomix' GeneIndexer

Positive results from Ardea Biosciences' ongoing drug-drug interaction study of RDEA594 and febuxostat

MedImmune to develop and commercialize Trellis Bioscience's anti-RSV antibodies

Bioequivalence and comparable toxicity of ADVENTRX Pharmaceuticals' ANX-514 and Taxotere affirmed

Chinese SFDA approves Tianyin Pharmaceutical's Pediatric Fever and Cough Oral Liquid

Sentinelle Medical showcases its new line of breast MRI coils at the RSNA meeting

Positive data from Provectus Pharmaceuticals' psoriasis and atopic dermatitis trials

Drug risk disclosures not read due to information overload, condensed version needed

Royal Philips Electronics highlights its interventional radiology/oncology solutions at the RSNA meeting

Driscoll Children's Hospital implements the CAREt bedside medication administration system

FORMA Therapeutics closes Series B financing to a total of $25.5 million

Human-animal bond offers significant benefits

Optoacoustics' FOMRI-III optical microphone now available for use in fMRI environments

Toshiba launches new education plan for healthcare staff

UC3M researchers developing a prototype for extracting drug interactions

New figures show steady decline in European cancer deaths, but variations exist between gender and countries

Pfizer, Protalix team up to develop and market plant-based enzyme for Gaucher’s disease treatment

50 U.S. Hospitals approve Osteotech's Plexur M bone-polymer biocomposite

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Latest News